What is Braftovi used to treat?
Braftovi is used in combination with other drugs to treat patients with advanced melanoma, advanced non-small cell lung cancer and advanced colorectal cancer with BRAF gene mutations.
Braftovi is an oral small molecule BRAF kinase inhibitor.
Melanoma
Braftovi (encorafenib) is used in combination with Mektovi (binimetinib) for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.
Roughly 50% of patients diagnosed with metastatic melanoma test positive for the BRAF mutation, and it is the most common genetic mutation in metastatic melanoma.
Braftovi is not indicated for the treatment of patients with wild-type BRAF melanoma.
Colorectal Cancer
Braftovi is used in combination with Erbitux (cetuximab) for the treatment of adult patients with
metastatic colorectal cancer (CRC) with a BRAF V600E mutation, as detected by an FDA-approved test, after prior therapy.
Braftovi is also used in combination with Erbitux (cetuximab) and mFOLFOX6 (fluorouracil, leucovorin and oxaliplatin) for the first-line treatment of patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
- This indication is approved under accelerated approval based on response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
BRAF mutations are estimated to occur in up to 15% of people with metastatic colorectal cancer.
Braftovi is not indicated for treatment of patients with wild-type BRAF CRC.
Non-Small Cell Lung Cancer
Braftovi is used in combination with Mektovi (binimetinib) for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as detected by an FDA-approved test.
BRAF mutations are estimated to occur in 2% to 5% of people with metastatic non-small cell lung cancer.
Braftovi is not indicated for the treatment of patients with wild-type BRAF NSCLC.
Related questions
- What is Mektovi used to treat?
- How long does it take for Keytruda to work?
- Pembrolizumab vs. nivolumab: How do they compare?
References
- Braftovi (encorafenib) prescribing information. Revised 12/2024. Pfizer Inc. New York, NY. Accessed Dec 29, 2024 at https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/210496s017lbl.pdf
Read next
How effective Is Keytruda for metastatic melanoma?
Keytruda (pembrolizumab) is an immunotherapy known as a PD-1 inhibitor, approved by the FDA for the treatment of unresectable or metastatic melanoma. This therapy has transformed the outlook for many patients with advanced melanoma, offering the potential for extended survival and durable responses in some cases. At 10 years, 34% of patients treated with Keytruda were still alive, compared to 23.6% for those treated with ipilimumab, another immunotherapy.
Continue reading
How effective are Opdivo and Yervoy when taken together?
Opdivo (nivolumab) and Yervoy (ipilimumab) are two anticancer medications. While they are both effective treatment options for many different types of cancer, research shows they work better when taken together for some types of cancer. The effectiveness of taking Opdivo and Yervoy depends on the individual person and what type of cancer they are treating. Continue reading
Opdivo vs Opdivo Qvantig: What is the Difference?
Opdivo and Opdivo Qvantig are both immunotherapy treatments containing nivolumab that help fight cancer by interfering with cancer cell growth and spread. However, they have several key differences in their administration method, approved uses, and patient eligibility. Continue reading
See also:
Aimovig
Learn about Aimovig (erenumab-aooe) a once-monthly, injectable medication that can be ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Emgality
Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for ...
Timolol
Timolol is used for angina, heart attack, high blood pressure, migraine, migraine prevention
Valproic acid
Valproic acid is used for bipolar disorder, cluster-tic syndrome, epilepsy, headache ...
Divalproex sodium
Divalproex sodium is used for bipolar disorder, borderline personality disorder, cyclothymic ...
Related medical questions
- What is Cotellic used for?
- How often should I have a colonoscopy with ulcerative colitis?
- What is the FOLFOX chemo regimen and is it effective?
- What is the success rate of Keytruda?
- What is the CAPOX (XELOX) chemotherapy regimen?
- What is the FOLFIRI chemo regimen and how does it work?
- Why do you need to take Xeloda with food?
- How long does oxaliplatin stay in your system?
- How many cycles of oxaliplatin can you have?
- How effective is Lumakras, what's the survival rate?
- What is the difference between Mvasi and Avastin?
- How long does Lonsurf increase survival in colorectal cancer?
- How effective is tucatinib (Tukysa) for breast cancer?
- What's the mechanism of action for tucatinib?
- Common Types of Cancer Medications
- What type of cancer is Tecentriq used to treat?
- What is the difference between Opdivo and Keytruda?
- What happens when you stop taking Opdivo for melanoma?
- Are there cost-saving programs for Tecentriq?
- How effective is atezolizumab (Tecentriq)?
- Is atezolizumab (Tecentriq) a chemotherapy or immunotherapy drug?
- Does atezolizumab (Tecentriq) cause hair loss?
- How is atezolizumab (Tecentriq) administered?
- Sunscreen Safety: What do you need to know?
Drug information
Related support groups
- Braftovi (2 questions, 3 members)
- Encorafenib (2 questions, 3 members)
- Melanoma - Metastatic (8 questions, 30 members)
- Colorectal Cancer (22 questions, 53 members)
- Melanoma (20 questions, 52 members)
- Skin Cancer (13 questions, 38 members)